Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Shanghai Children'S Medical Center Shanghai Jiaotong University School Of Medicine manages a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently has 1 pending office action. This 1 pending office action is being reviewed by 1 distinct examiner. Examination is occurring within 1 distinct art unit, indicating that the institution's current patent activity is focused on a specific biotechnological advancement. LARA, CAROLINE MONSERRAT is the busiest examiner for this portfolio, with 1 busiest examiner pending office action.
This 1 busiest examiner pending office action constitutes the entirety of the active workload for the institution. With only 1 distinct examiner and 1 distinct art unit involved, the prosecution of these medical innovations is currently concentrated in a single area of the office. Practitioners must ensure that their strategy aligns with the specific technical standards and examination practices of this 1 distinct examiner. The lack of multiple distinct examiners means the institution is not currently navigating the varying requirements of different technical centers within the Biotechnology & Pharmaceuticals field.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LARA, CAROLINE MONSERRAT | 1 | 85.7% | +16.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18279765 | USE OF ENHANCED TBX1 EXPRESSION IN REPAIRING HEART TISSUE INJURY | LARA, CAROLINE MONSERRAT | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18279765 | USE OF ENHANCED TBX1 EXPRESSION IN REPAIRING HEART TISSUE INJURY | LARA, CAROLINE MONSERRAT | — |
| Art Unit | Apps |
|---|---|
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18279765 | USE OF ENHANCED TBX1 EXPRESSION IN REPAIRING HEART TISSUE INJURY | LARA, CAROLINE MONSERRAT | 1658 | §102§103§112 | Non-Final OA | — | Pending | Aug 31, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialShanghai Children'S Medical Center Shanghai Jiaotong University School Of Medicine has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Caroline Monserrat Lara has the most, with 1 of Shanghai Children'S Medical Center Shanghai Jiaotong University School Of Medicine's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
